A. Kampikaho et Lm. Irwig, A RANDOMIZED TRIAL OF PENICILLIN AND STREPTOMYCIN IN THE PREVENTION OF POSTPARTUM INFECTION IN UGANDA, International journal of gynaecology and obstetrics, 41(1), 1993, pp. 43-52
We report findings of a randomized trial of penicillin and streptomyci
n to prevent post-partum infection conducted on 737 women who delivere
d consecutively at Kawempe Maternity Centre (KMC) in Kampala from 1st
October, 1989 to 31st May, 1990. The objectives were: (i) to identify
clinical post-partum infection using at least two of its symptoms and
signs (fever, lower abdominal pain, lower abdominal tenderness, vagina
l discharge); (ii) to identify the causes of post-partum infection usi
ng laboratory methods; and (iii) evaluate the effectiveness of prophyl
actic fortified procaine penicillin (PPF) and streptomycin on post-par
tum infection. Clinical infection occurred in 36.4% of the group not g
iven antibiotics, 23.3% in the PPF group and 20.3% in the streptomycin
group. Laboratory-confirmed infection occurred in 15.5% of the group
not given antibiotics, 9.2% in the PPF group and 8.4% in the streptomy
cin group. However, severe laboratory-confirmed infection (severe clin
ical infection plus positive laboratory findings) occurred in 4.9% of
the group not given antibiotics, 6.1% in the PPF group and 6.6% in the
streptomycin group. In general, the organisms isolated included enter
obacteria (35.9%), yeast and protozoa (31.6%), staphylococci (23.9%),
streptococci (69%) and Neisseria (1.7%). The advantage of PPF and stre
ptomycin was evident in most subgroups defined by clinical characteris
tics or laboratory findings. In view of the findings in this study, we
believe that prophylactic antibiotics given in labor may have a role
to play at reducing the incidence of post-partum infection. However, a
s the cost of antibiotics in developing countries is significant, the
development of resistant organisms due to indiscriminate antibiotic us
e is also a concern and health resources are best used when targeted a
t specific populations, we feel that antibiotic prophylaxis should not
be used routinely and that a more realistic view can be obtained by s
tudying high-risk groups of women with more severe infection.